Patrick Holmes is an industry veteran with over 30 years of experience in the pharmaceutical industry in a broad range of roles, most notably in the global policy arena.  Patrick is the Science and Innovation Policy Lead at Pfizer based in New York and heads a team responsible for developing global health policy initiatives and evidence across a series of policy issues supporting Pfizer’s R&D-driven organization, including driving affordable patient access to medicines, while allowing the company to continue to develop and deliver innovative treatments. Issue areas include market-based R&D incentives, value and innovation frameworks and sustainable patient-centric health systems.

Patrick brings a range of experiences to his current role having worked across multiple areas of the biopharmaceutical business during his 30-year career at Pfizer. Patrick joined Pfizer as a marketing associate in 1990 and held multiple positions of increasing responsibility in both US and global marketing spanning a range of therapeutic areas including hypertension, lipid lowering, arrhythmia, diabetes, erectile dysfunction, and allergies. Patrick then switched to a strategic planning role where he was responsible for evaluating new product opportunities and providing strategic input on behalf of the US commercial organization. He then led the Portfolio and Decision Analysis group, supporting strategic decisions and investment tradeoffs across Pfizer’s development portfolio. His last assignment prior to joining the policy team was Vice President, Strategy and Portfolio Support, providing comprehensive insights and identifying key emerging trends for Pfizer leaders.